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doi:10.1016/j.artres.2010.06.003Abstract Conventionally, the relationship between parent and daughter vessels at vascular
bifurcations has been expressed by the junction exponent (x), and deviations of this parameter
from the optimal conditions predicted by Murray’s law (xZ 3) have been shown to be associ-
ated with vascular disease. However, the junction exponent is normally calculated iteratively
from diameter measurements, and Monte-Carlo simulation studies show the junction exponent
to be biased in the presence of measurement noise.
We present an alternative parameter, referred to as optimality ratio, that is simpler to
compute and also more robust in the presence of noise.
To demonstrate the sensitivity of the optimality ratio to alterations in topography of the
retinal vascular network, we analysed the effect of inducing endothelial dysfunction by infu-
sion of NG-monomethyl-L-arginine (L-NMMA), a nitric oxide synthase inhibitor, compared to
placebo in a double-blind crossover study. The optimality ratio showed a significant increase
(pZ 0.03) during infusion of L-NMMA compared to placebo.
We propose that a measure of the extent of departure of optimality ratio from its
optimal value of 21/3 may be a useful indicator of microvascular endothelial dysfunction
in vivo.
ª 2010 Association for Research into Arterial Structure and Physiology. Published by Elsevier
B.V. All rights reserved.c.uk (N.W. Witt).
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Figure 1 Junction exponent as a function of non-dimensional
daughter diameters z1 and z2.
76 N.W. Witt et al.Introduction
The relationship between diameters of parent and daughter
vessels at a bifurcation is conventionally described by the
junction exponent (x), defined by the relationship
dx0Zd
x
1 þ dx2 ð1Þ
where d0 is the diameter of the parent vessel and d1, d2 are
the diameters of the daughter vessels. Murray’s law1
predicts that under conditions of optimum power loss in
the bifurcation, the junction exponent is equal to 3. Sher-
man2 and LaBarbera3 reviewed data from a variety of other
workers, and showed that with the exception of the very
largest vessels, healthy arteries and veins appeared to follow
Murray’s law closely. In contrast, diseased vessels exhibit
deviations from the diameter relationship predicted by
Murray’s law. Hutchins et al.4 found a reduction in junction
exponent in diseased human coronary arteries compared to
normal subjects. In the retinal arteries, Stanton et al.5 have
shown a reduction in junction exponent with age, and
Chapman et al.6 have found similar alterations to retinal
bifurcation geometry in peripheral artery disease.
The junction exponent is a convenient mathematical
description of the diameter relationships at bifurcations,
and the expected behaviour of the junction exponent has
been studied theoretically by optimisations based on
alternative cost functions.7 Nevertheless, an experimen-
tally calculated junction exponent cannot in general be
related directly to fundamental hemodynamic or physio-
logical characteristics. Due to the exponential formulation,
it is usual to calculate the junction exponent from a set of
diameter measurements by an iterative process or a look-
up table, thus adding computational complexity. Further-
more, the junction exponent can be expected to suffer
excessive bias and variability in the presence of noise in the
measurements of individual vessel diameters.
Accordingly, we propose an alternative parameter to
characterise the optimality of the relationship between
vascular diameters at a bifurcation, referred to as the
optimality ratio, which overcomes the drawbacks with the
junction exponent.
We report here first on the derivation of the optimality
ratio, and go on to describe Monte-Carlo simulations which
demonstrate improved robustness to measurement noise on
individual vesselmeasurements.Wehave also calculated the
optimality ratio from retinal measurements made in a clin-
ical study, thereby demonstrating the sensitivity and utility
of the optimality ratio as a measure of arteriolar changes
resulting from inhibition of nitric oxide (NO) synthase
induced by infusion of NG-monomethyl-L-arginine (L-NMMA).
Derivation of optimality ratio
For convenience, we define non-dimensional variants of the
daughter diameters at a vascular bifurcation
z1Z
d1
d0
; z2Z
d2
d0
ð2Þ
Hence, from Eqs. (1) and (2) the definition of junction
exponent may be re-stated aszx1 þ zx2Z1 ð3Þ
Insight may be gained into the behaviour of the junction
exponent (x) by plotting it against the non-dimensional
daughter diameters z1 and z2 as shown in Fig. 1. The line
z1Z z2 represents the set of perfectly symmetrical bifurca-
tions, and departures from this line are associated with
increasing asymmetry. In general, the projection of a point in
the z1, z2 plane, onto the line z1Z z2 represents the mean
daughter diameter, non-dimensionalised by the parent
diameter. We will refer to this as the mean diameter ratio
gZ
d1 þ d2
2d0
Z
z1 þ z2
2
ð4Þ
An evident feature of the illustrated surface in Fig. 1 is
that the relationship between mean diameter ratio (g) and
junction exponent (x) appears largely insensitive to bifur-
cation asymmetry. Accordingly, a parameter based on g
offers the prospect of a robust, statistically well-behaved
alternative to the junction exponent. Detailed examination
of plots of g against x for a range of symmetrical and
asymmetrical bifurcations reveal a small residual depen-
dency on asymmetry concentrated in the region of opti-
mality (xZ 3). Since small deviations are of particular
interest in this region, it is desirable to correct for this.
Conventionally, the asymmetry factor (a) of a bifurca-
tion is defined8 as follows
aZ

d1
d2
2
Z

z1
z2
2
where d1;d2 > 0 and d1  d2 ð5Þ
so that a perfectly symmetrical bifurcation is described by
aZ 1.
By algebraic manipulation of Eqs. (3)e(5) it may be
shown that for a general bifurcation
gZ
1þ a1=2
2ð1þ ax=2Þ1=x
: ð6Þ
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non-dimensional daughter diameter is given by
gZ
1þ a1=2
2ð1þ a3=2Þ1=3
ð7Þ
that is dependent only on asymmetry, and for a symmet-
rical bifurcation (i.e. aZ 1) takes the constant value
g))Z
1
21=3
Z0:7937: ð8Þ
We therefore propose a ratio to characterise the opti-
mality of the diameter relationships at a bifurcation, that
we refer to as the optimality ratio
GratioZfðaÞg ð9Þ
where the correction factor
fðaÞZg
))
g)
Z

4ð1þ a3=2Þ1=3
ð1þ a1=2Þ ð10Þ
adjusts the measured mean diameter ratio, to take account
of the measured asymmetry, yielding the approximate
value that would have been obtained for a symmetrical
bifurcation. For a bifurcation obeying Murray’s law, the
correction is exact.
By algebraic simplification of Eqs. (4), (9) and (10)
GratioZ
 
d31 þ d32
2d30
!1=3
: ð11Þ
Thus, the optimality ratio (Gratio) exhibits the desirable
property that under optimal conditions predicted by Mur-
ray’s law it equals the constant 21/3, given by Eq. (8),
irrespective of asymmetry.
The dependence of the correction factor f(a) on asym-
metry factor is illustrated in Fig. 2. It can be seen that for
reasonably symmetric bifurcations (a> 0.4), the correction
factor has only a small effect on the overall non-dimen-
sional daughter diameter, affecting it by less than 5%.
However, for less symmetrical bifurcations, the effect of
the correction factor is amplified, and reliable derivation of
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Figure 2 Dependence of correction factor on asymmetry.measurement noise, particularly in the diameter of the
smaller daughter vessel. Therefore, wherever possible, we
advocate exclusion of highly asymmetrical bifurcations
(a< 0.4) from consideration of vessel diameter optimality.
In practice this also avoids difficulties in measuring very
small diameters.
The behaviour of the corrected optimality ratio may be
illustrated by plotting the relationship with the junction
exponent for various asymmetry factors, as shown in Fig. 3.
This confirms that for a junction exponent of 3 the value of
optimality ratio remains constant irrespective of asymme-
try, and also shows only a negligible sensitivity to asym-
metry away from optimal conditions.
For convenience we also define the optimality index
GindZ2
1=3Gratio ð12Þ
that possesses similar characteristics to the optimality
ratio, except that it takes the value of 1 under optimum
conditions.
Finally, we define the optimality deviation, a measure of
the extent of deviation from the optimum conditions
GdevZ
Gratio  121=3
: ð13Þ
Robustness to measurement noise
Monte-Carlo simulations were performed to assess the
robustness of the optimality ratio to measurement noise, in
comparison with the junction exponent.
A symmetrical optimal bifurcation (i.e. xZ 3 and
GratioZ 0.7937) was considered with the independent
addition to each vessel of normally distributed measure-
ment noise of zero mean, and standard deviation corre-
sponding to 5, 10 and 15% of the vessel diameter. After 2000
trials, the mean biases in junction exponent and optimality
ratio between ‘measured’ and true values were calculated,
together with the standard deviation of differences. In
order to allow meaningful comparison, the results from the
junction exponent were scaled to units of optimality ratio
through multiplication by DGratio/DxZ 0.06113, derived0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
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Figure 3 Junction exponent against optimality ratio.
Table 1 Effect of measurement noise on junction expo-
nent and optimality ratio.
SD of measurement
noise (% of vessel
diameter)
Mean bias (SD)
Units of optimality ratio
From junction
exponent
From optimality
ratio
5 0.019 (0.087) 0.0030 (0.049)
10 0.060 (0.23) 0.0089 (0.10)
15 0.042 (0.32) 0.024 (0.16)
78 N.W. Witt et al.analytically from Eqs. (3), (4) and (9) at the point of opti-
mality (xZ 3). The results of this Monte-Carlo simulation
are shown in Table 1.
It is evident from Table 1 that the optimality ratio is less
severely affected by the simulated measurement noise
than the junction exponent. For modest noise having
standard deviation of up to 10% of the vessel diameter, the
bias in the optimality ratio is less than one sixth of the value
arising from the junction exponent. Furthermore, the
scatter between ‘measured’ and true values of optimality
ratio is about half that arising from the junction exponent.
A further trial was performed to evaluate how the
variability and bias in the optimality ratio arising from
measurement noise depend on the characteristics of the
bifurcation under study. Table 2 shows the result of
applying measurement noise of zero mean and standard
deviation of 10% of vessel diameter to a selection of
bifurcations characterised by optimality ratio and asym-
metry factor.
These findings confirm that the optimality ratio remains
well behaved through the range of bifurcations that are
likely to be subject to clinical investigation.
Application to clinical data
Methods
To examine the clinical utility of the optimality ratio in
characterising the diameter relationships at a vascular
bifurcation, an analysis was undertaken of retinal micro-
vascular data following induction of endothelial dysfunc-
tion using an NO-synthase inhibitor.
Data were obtained from a double-blind, randomised,
placebo-controlled crossover trial involving six healthy
normotensive (BP< 140/90 mmHg) male volunteers (age
22e32 years). All volunteers were screened for evidence ofTable 2 Results of Monte-Carlo simulation of the effect of me
mality ratio (Gratio).
a Mean bias (SD)
GratioZ 0.6 GratioZ 0.7 G
1.0 0.008 (0.075) 0.009 (0.089) 0
0.8 0.008 (0.077) 0.010 (0.090) 0
0.6 0.008 (0.077) 0.009 (0.093) 0
0.4 0.011 (0.082) 0.009 (0.094) 0concomitant disease by physical examination, as well as
biochemical and haematological tests. The studywas carried
out in accordance with the principles of the Declaration of
Helsinki (1989) of theWorld Medical Association. All subjects
gave written informed consent, and the local research ethics
committee approved the study protocol.
Each subject received a 5-min intravenous infusion of
L-NMMA (Clinalfa AG, La¨ufelfingen, Switzerland) (3mg kg1
bodyweight in 0.9% saline) or matched placebo (20 ml 0.9%
saline) in random order on 2 occasions separated by 2e7
days. On each occasion, subjects were required to abstain
from alcohol, smoking and caffeine for 24 h prior to the
study, and remained seated comfortably in a quiet room for
2 h during each phase of the study. The right pupil was
dilated using a topical mydriatic (1% tropicamide; Chauvin
Pharmaceuticals, Romford, England) and an intravenous
cannula was sited in the dorsum of the left hand for infusion
of study drugs. Brachial systolic and diastolic blood pres-
sure and heart rate were measured at five-minute intervals
for 20 min prior to, and for 1 h following infusion of the
study drugs, using a validated automated oscillometric
blood pressure monitor (Omron HEM-705 CP; Omron, Tokyo,
Japan). Red-free 35 mm retinal photographs were taken on
Ilford FP4 (125 ASA) photographic film (Ilford Imaging UK
Ltd., Knutsford, England) using a fundus camera with a 30
field of view (Kowa FX-50R, Kowa, Tokyo, Japan). Duplicate
views of the superior temporal quadrants were taken at
20 min and 10 min prior to infusion of the study drug and at
10, 20, 30 and 60 min following infusion.
Analysis of the retinal images was performed by a single
trained observer using a validated, purpose built operator-
directed image analysis package based on the Sliding Linear
Regression Filter (SLRF) method of vessel diameter
measurement, as described elsewhere.9 The photographic
negatives were digitised using a Nikon 35 mm film scanner
(LS-1000, Nikon, Tokyo, Japan), yielding images of
2800 2400 pixels in size. A pixel corresponded to an
absolute distance of order 5 mm at the retina. In each
subject, the same bifurcations were identified (5 per
subject) and at each bifurcation the diameters of the
parent vessel (d0), and daughter vessels (d1 and d2) were
measured at each time point. All vessel diameters were
measured in pixels, and no attempt was made to calculate
actual arteriolar diameters due to uncertainties introduced
by the refractive index of the eye and the distance between
the retina and the camera lens.
Optimality ratio was calculated at each bifurcation in
accordance with Eq. (11), and the median difference from
baseline calculated at each time point within each subject.
Data are presented as mean (SD) and statistical comparisonasurement noise at different asymmetry factors (a) on opti-
ratioZ 0.8 GratioZ 0.9 GratioZ 1.0
.014 (0.106) 0.014 (0.114) 0.018 (0.128)
.017 (0.104) 0.011 (0.113) 0.017 (0.126)
.012 (0.102) 0.011 (0.119) 0.015 (0.130)
.009 (0.103) 0.015 (0.121) 0.016 (0.135)
Table 4 Effect on measured variables of L-NMMA
compared with placebo.
Marginal effects
(placeboeL-NMMA)
p Value
Systolic BP, mmHg 9.0 (4.1, 13.8) < 0.001
Diastolic BP, mmHg 4.5 (2.3, 6.6) < 0.001
Heart rate, bpm 1.2 (3.6, 1.3) 0.4
Diameter d0, pixels 0.72 (1.38, 0.06) 0.03
Bifurcation angle, degrees 1.1 (2.8, 0.7) 0.2
Optimality ratios 0.022 (0.002, 0.043) 0.03
Data are marginal means (95% confidence intervals).
Table 3 Baseline measurements in placebo and L-NMMA
phases.
Placebo L-NMMA
Systolic BP, mmHg 129 (11) 127 (14)
Diastolic BP, mmHg 69 (9) 72 (9)
Heart rate, bpm 68 (7) 68 (11)
Diameter d0, pixels 28.3 (3.1) 27.9 (3.8)
Bifurcation angle, degrees 77 (10) 79 (9)
Optimality ratios 0.784 (0.006) 0.795 (0.021)
Data are means (SD).
Novel measure of bifurcation optimality 79of placebo vs. L-NMMA was performed using linear mixed
models in Stata 11.0 to take account of repeated
measures,10 with p< 0.05 being considered significant.
Results
Baseline variables did not differ significantly between
measurements made on the occasions of placebo and L-NMMA
infusions (Table 3) and optimality ratios at baseline did not
differ significantly from the predicted optimum value of
0.794. The optimality ratio of retinal bifurcations increased
significantly (pZ 0.03) following infusion of L-NMMA
compared with placebo (Fig. 4; Table 4). L-NMMA infusion also
significantly increased systolic (p< 0.001) and diastolic BP
(p< 0.001) and reduced retinal arteriolar diameter (pZ 0.03)
(Table 4). Differences in heart rate and bifurcation angle
between L-NMMA and placebo were not statistically signifi-
cant. There was no significant statistical interaction between
the reduction in retinal arteriolar diameter and bifurcation
order suggesting that L-NMMA induces a generalized vasocon-
striction in arterioles up to 5th order.
Discussion
Previous studies implicate NO produced by the endothelium
in maintaining the optimal configuration of vascular
networks.11e13 In isolated rabbit ear preparations with
unimpaired endothelial function, junction exponents-0.03
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Figure 4 Change in optimality ratio (mean (SD)) during
active and placebo phases of trial.remained close to theoretical optimum values even when
preparations were vasoconstricted by serotonin. In contrast,
whenNOwas inhibitedbyhaemoglobin, vasoconstrictionwas
associated with marked deviation of junction exponents
from the optimum.
In the present study, infusion of L-NMMA, an inhibitor of
NO synthase, resulted in a rise in blood pressure compared
to placebo, consistent with previous studies that showed
a rise in systemic vascular resistance following systemic
infusions of L-NMMA.14,15 Two previous studies, one using
fluorescein angiograms the other red-free images5,16 have
both reported no difference in junction exponents between
normotensive and hypertensive subjects, although ageing
was associated with a decline in junction exponents.5
Accordingly, the increase in optimality ratio observed
following infusion of L-NMMA appears most likely to have
arisen from inhibition of NO synthase rather than being
secondary to elevation of systemic blood pressure.
These data are consistent with previous in vitro obser-
vations, and indicate that optimality ratio is altered by
inhibition of NO synthase through L-NMMA infusion.
Furthermore, it supports the hypothesis that NO is impor-
tant for the maintenance of optimal arterial topography in
vivo in man.
Conclusions
We have derived a parameter, referred to as the optimality
ratio, aimed at characterising the diameter relationships at
a vascular bifurcation. This parameter is based on the mean
non-dimensional daughter diameter, but includes a correc-
tion factor to reduce the effect of bifurcation asymmetry. At
an optimum bifurcation in accordance with Murray’s law (i.e.
junction exponentZ 3) the optimality ratio adopts a constant
value of 21/3, and rises monotonically with increasing junc-
tion exponent. The optimality ratio can be readily calculated
directly frommeasurements of vessel diameter, in contrast to
the junction exponent which generally requires an iterative
solution, or else cumbersome look-up tables.
Monte-Carlo simulation studies demonstrate that the
optimality ratio also offers improved robustness, compared
to the junction exponent, in the presence of measurement
noise in individual vessels. For measurement noise having
standard deviation up to 10% of vessel diameter, bias in
optimality ratio was less than one sixth of that in junction
exponent, and scatter in the region of one half, after
adjustment for relative scaling.
80 N.W. Witt et al.In data obtained from a double-blind placebo-controlled
clinical investigation, infusion of L-NMMA, a NO-synthase
inhibitor, was shown to increase significantly the optimality
ratio of retinal vessels, compared to placebo. This supports
the hypothesis that NO is important for the maintenance of
optimal arterial topography in man. Moreover, we propose
that a measure of the extent of departure of optimality
ratio from its optimal value of 21/3, may be a useful
indicator of microvascular endothelial dysfunction in vivo.
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